Wednesday, February 9, 2022

Teva Pharma Q4 Profit Beats Estimates

Teva Pharmaceutical Industries Ltd. (TEVA) reported fourth quarter non-GAAP earnings per share of $0.77, compared to $0.68, a year ago. On average, 14 analysts polled by Thomson Reuters expected the company to report profit per share of $0.73, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/weYuCfS
via IFTTT

No comments:

Post a Comment